Abogada, Airesh .
HRN: 23-65-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
CO-AMOXICLAV 625MG (TAB)
09/06/2023
09/13/2023
PO
625 Mg
BID
Post NSD Leaking BOW
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes